ALTEROLA BIOTECH INC. (OTC QB: ABTI) is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary product platform in a broad range of disease areas. The Company has a number of proprietary drug pipeline candidates including cannabinoi...
ALTEROLA BIOTECH INC. (OTC QB: ABTI) is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary product platform in a broad range of disease areas. The Company has a number of proprietary drug pipeline candidates including cannabinoids, cannabinoid-like molecules and non-cannabinoid molecules, which are under development for a range of indications. ABTI is also focused on producing quality, low cost of goods ingredients for the pharmaceutical, food and cosmetic sectors, from synthetic, biosynthetic and botanical sources. It is also focused on improving the drug delivery of such classes of compounds and has a range of proprietary technologies in development to enhance the delivery and bioavailability of its product portfolio. Geographically the Company has a presence in the UK, Ireland, Netherlands (Europe), USA, Australia, and China.
Mehr anzeigen